Remote First Nations will be prioritized in rollout of COVID-19 treatment drug, Indigenous Services Canada says – CTV News
Prince Albert –
People living in remote, isolated Indigenous communities, who are at greater risk of getting COVID-19, have been prioritized to receive some of the first shipments of a newly approved Pfizer drug to treat the illness, according to Indigenous Services Canada (ISC).
“We’ve worked with our colleagues at public health agencies, provinces and territories in order to prioritize the allocation,” said ISC Chief Medical Officer of Public Health Dr. Tom Wong during a virtual news conference on Thursday.
Pfizer’s Paxlovid is an oral antiviral treatment prescribed by a doctor and administered in pill form. It’s an antiviral treatment of the SARS-CoV-2 virus, it can reduce symptoms from and shorten the period of illness.
